Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic study of HP-6050 microneedle at different application sites
jRCT2031240538Completed
- Sponsor
- Hisamitsu Pharmaceutical Co., Inc.
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of HP-6050 in delirium, psychomotor agitation and irritability, sponsored by Hisamitsu Pharmaceutical Co., Inc. Primary endpoints: Pharmacokinetics of HP-6050, Safety of HP-6050 and 1 more. Started Jan 2025; status: completed.
02
Drugs
HP-6050
03
Conditions
deliriumpsychomotor agitationirritability
Beyond the preview
Go deeper on jRCT2031240538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031240538.